3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasms
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Sarcoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Carcinoma, Squamous Cell
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Rhabdomyosarcoma
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Pilonidal Sinus
1
Interventions
Taxes
1
Standard of Care
1
Panitumumab
1
Pancreaticoduodenectomy
1
Optical Imaging
1
Losartan
1
Gemcitabine
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma
×
Surgical Procedures, Operative
×
90 days
×
Clear all
No trials found.